Vulcan Biosciences

Vulcan Biosciences Expands Leadership Team And Strengthens Drug Development Capabilities

Birmingham, AL, February 12th 2020 – Vulcan Biosciences, Inc. announced today the hiring of Omar Flores, Ph.D., M.B.A., as Chief Executive Officer. Dr. Flores has prior experience taking early s...

Multiple Sclerosis Drug Discovery Program Yields Two Novel Drugs With Clinical Efficacy In The EAE Mouse Model

Birmingham, AL, December 9th 2019 – The results obtained from an unbiased and thorough analysis of potential drug targets in multiple sclerosis has been successful, culminating in the identification o...

Vulcan Biosciences Closes A Seed Investment Round To Identify New Drugs For Multiple Sclerosis

Birmingham, AL, August 1st 2019 – Vulcan Biosciences, Inc. a biotechnology company focused on finding more effective treatments for patients with multiple sclerosis, announced today that it has secure...

Vulcan Biosciences Drug Discovery Tool Is Used by The FDA For Internal Research

Birmingham, AL, April 17th 2019 – The U.S. Food and Drug Administration (FDA) has chosen to partner with Vulcan Biosciences Inc. (formerly Vulcan Analytical) for cutting-edge blood protein research in...